The Complex Coronary Revascularization Program at UTHealth Houston is dedicated to providing advanced and comprehensive care for individuals with coronary artery disease. This condition, characterized by the narrowing of the heart’s arteries due to cholesterol buildup, can lead to various heart-related symptoms and complications.
Our program specializes in addressing the needs of patients who may have encountered challenges elsewhere in their treatment journey. This includes individuals who:
If you are experiencing symptoms such as chest discomfort, chest pain, or shortness of breath due to unresolved coronary artery disease, we encourage you to contact us to request a consultation. Our team of experts is committed to evaluating your condition and providing you with personalized, state-of-the-art treatment options tailored to your unique needs.
The Complex Coronary Intervention Program is made up of a highly experienced clinical team that plans and applies a treatment process that is tailored to each patient’s condition, age, symptoms and risk factors. Physicians draw upon several non-invasive and invasive diagnostic tests and procedures to determine the best line of treatment. These diagnostic procedures include:
Our physicians are at the forefront when it comes to the latest treatment and therapies for coronary artery disease. Some of the advanced treatments and procedures offered within the Complex Coronary Intervention Program include:
Specialists within our state-of-the-art Cardiac Catheterization Laboratory provide advanced treatments for coronary artery disease. While highly skilled in performing difficult procedures, our providers focus on patient care first, with improving survival or quality of life as the main determinants of decision to treat with medications, percutaneous interventions, or bypass surgery.
Our leading interventional cardiologists also perform “unprotected” left main coronary artery and other high-risk percutaneous coronary interventions using percutaneous left ventricular support devices.